* Document jointly prepared by Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR), Sociedade Brasileira de Mastologia (SBM) and Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO). 1. Coordinator of the National Commission on Mammography, Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR). 2. Members of the National Commission on Mammography, Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR). 3. Invited Member of the National Commission on Mammography, Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR). 4. Members of the National Commission on Mammography, Sociedade Brasileira de Mastologia (SBM). 5. Members of the National Commission on Mammography, Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO).
ObjectiveTo present the current recommendations for breast cancer screening in Brazil,
as devised by the Brazilian College of Radiology and Diagnostic Imaging, the
Brazilian Breast Disease Society, and the Brazilian Federation of
Gynecological and Obstetrical Associations.Materials and methodsWe analyzed scientific studies available in the Medline and Lilacs databases.
In the absence of evidence, the recommendations reflected the consensus of a
panel of experts.RecommendationsAnnual mammography screening is recommended for women 40-74 years of age.
Among women ≥ 75 years of age, annual mammography screening should be
reserved for those with an expected survival > 7 years. Complementary
ultrasound should be considered for women with dense breasts. Complementary
magnetic resonance imaging is recommended for women at high risk. When
available, an advanced form of mammography known as tomosynthesis can be
considered as a means of screening for breast cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.